Azadyne speaking at FASEB RNA conference
Great to see one of the Azadyne founders, Prof Vincent Kelly, of Trinity College Dublin speaking today on ‘RNA modification as a target for autoimmunity’ at FASEB meeting on “RNA associated mechanisms: In immunity and Disease”, in Steamboat, Colorado.
Azadyne Announce Funding Round
Azadyne, which is developing a new approach to the treatment of autoimmune diseases, announced that it has raised £1.5million (€1.75 million) in its most recent funding round.